\
&
Contact us
Health Agro-Food, Environment Joint Research Center
The Joint Research Centre (JRC) of the Commission invites applications for hands-on training at its state-of-the-art Nanobiotechnology Laboratory. This call offers researchers the opportunity to strengthen expertise in nanomaterials, nanomedicines, advanced materials, and micro(nano)plastics, with a focus on their detection, characterisation, and i... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.